Skip to main content
Figure 5 | Molecular Medicine

Figure 5

From: Therapeutic Potential of SH2 Domain-Containing Inositol-5′-Phosphatase 1 (SHIP1) and SHIP2 Inhibition in Cancer

Figure 5

Identification of pan-SHIP inhibitors. (A–C) (i) Structures of 1PIE (A), 2PIQ (B) and 6PTQ (C). (ii) Fluorescence polarization assay shows inhibition of recombinant SHIP1 activity by 100 µmol/L 1PIE (A), 2PIQ (B) and 6PTQ (C). The decrease in mean polarization units without compound (−) is inhibited by adding 1PIE, 2PIQ or 6PTQ to the reaction mix (+). (iii) Comparison of efficiency of recombinant SHIP1 and SHIP2 inhibition by increasing concentrations of inhibitors, as determined by either Malachite Green assay (2PIQ, B) or fluorescence polarization assay (1PIE [A] and 6PTQ [C]). (D) Recombinant SHIP2 and SHIP1 precipitated from OPM2 cell lysates were allowed to dephosphorylate PtdIns(3,4,5)P3 in the absence (DMSO) or presence of inhibitors. OCRL, precipitated from OPM2 cell lysates, was allowed to dephosphorylate PtdIns(4,5)P2 in the presence of inhibitors or DMSO control. Free phosphate groups were detected with Malachite Green reaction. The percentage inhibition of phosphatase activity in two independent immunoprecipitation experiments is represented (means ± SEM).

Back to article page